{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:15:11Z","timestamp":1771067711108,"version":"3.50.1"},"reference-count":176,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020M3A9B3026182"],"award-info":[{"award-number":["2020M3A9B3026182"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C1050"],"award-info":[{"award-number":["HI17C1050"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liver diseases, despite the organ\u2019s high regenerative capacity, are caused by several environmental factors and persistent injuries. Their optimal treatment is a liver transplantation. However, this option is limited by donor shortages and immune response issues. Therefore, many researchers have been interested in identifying the therapeutic potential in treating irreversible liver damage based on stem cells and developing suitable therapeutic agents. Mesenchymal stem cells (MSCs), which are representative multipotent stem cells, are known to be highly potential stem cell therapy compared to other stem cells in the clinical trial worldwide. MSCs have therapeutic potentials for several hepatic diseases such as anti-fibrosis, proliferation of hepatocytes injured, anti-inflammation, autophagic mechanism, and inactivation of hepatic stellate cells. There are much data regarding clinical treatments, however, the data for examining the efficacy of stem cell treatment and the correlation between the stem cell engraftment and the efficacy in liver diseases is limited due to the lack of monitoring system for treatment effectiveness. Therefore, this paper introduces the characteristics of microRNAs (miRNAs) and liver disease-specific miRNA profiles, and the possibility of a biomarker that miRNA can monitor stem cell treatment efficacy by comparing miRNAs changed in liver diseases following stem cell treatment. Additionally, we also discuss the miRNA profiling in liver diseases when treated with stem cell therapy and suggest the candidate miRNAs that can be used as a biomarker that can monitor treatment efficacy in liver diseases based on MSCs therapy.<\/jats:p>","DOI":"10.3390\/ijms22010239","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T10:04:46Z","timestamp":1609236286000},"page":"239","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling"],"prefix":"10.3390","volume":"22","author":[{"given":"Minyeoung","family":"Kweon","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology, University of Glasgow, Glasgow G12 8QQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-5190","authenticated-orcid":false,"given":"Jae Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, CHA University, Seongnam 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-8128","authenticated-orcid":false,"given":"Ji Hye","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, CHA University, Seongnam 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-7157","authenticated-orcid":false,"given":"Gi Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, CHA University, Seongnam 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.276.5309.60","article-title":"Liver regeneration","volume":"276","author":"Michalopoulos","year":"1997","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ajpath.2015.06.004","article-title":"Hepatic progenitor cells in action: Liver regeneration or fibrosis?","volume":"185","author":"Kaur","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3904\/kjim.2016.268","article-title":"Reversal of liver cirrhosis: Current evidence and expectations","volume":"32","author":"Jung","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: A systematic analysis for the global burden of disease study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_8","first-page":"17","article-title":"A review on laboratory liver function tests","volume":"3","author":"Gowda","year":"2009","journal-title":"Pan. Afr. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3748\/wjg.v22.i4.1523","article-title":"Liver transplantation in acute liver failure: A challenging scenario","volume":"22","author":"Mendizabal","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/gut.2008.175380","article-title":"Artificial and bioartificial liver devices: Present and future","volume":"58","author":"Carpentier","year":"2009","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccc.2016.03.003","article-title":"Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure","volume":"32","author":"Karvellas","year":"2016","journal-title":"Crit. Care Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/157488812799218956","article-title":"Clinical applications of mesenchymal stem cells in the treatment of fracture non-union and bone defects","volume":"7","author":"Shekkeris","year":"2012","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4254\/wjh.v10.i12.907","article-title":"Stem cell transplantation for the treatment of end-stage liver disease","volume":"10","author":"Wu","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biotechadv.2018.03.011","article-title":"Stem cells: Their source, potency and use in regenerative therapies with focus on adipose-derived stem cells\u2014A review","volume":"36","author":"Bacakova","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1248012","DOI":"10.1126\/science.1248012","article-title":"Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control","volume":"346","author":"Clevers","year":"2014","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157489210789702235","article-title":"Stem cell patents: An innovative approach to anti-cancer drug discovery","volume":"5","author":"Navone","year":"2010","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-74470-4_5","article-title":"Stem cell therapies for neurodegenerative diseases","volume":"1056","author":"Sugaya","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.3390\/ijms15057500","article-title":"Current status in the therapy of liver diseases","volume":"15","author":"Uhl","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3346\/jkms.2015.30.10.1405","article-title":"Therapeutic effects of mesenchymal stem cells for patients with chronic liver diseases: Systematic review and meta-analysis","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3389\/fphar.2019.01667","article-title":"Molecular biomarkers in drug-induced liver injury: Challenges and future perspectives","volume":"10","author":"Fu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1397344","article-title":"Overview of microrna biology","volume":"35","author":"Mohr","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2015.12.005","article-title":"Emergence of exosomal mirnas as a diagnostic biomarker for alzheimer\u2019s disease","volume":"360","author":"An","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.toxrep.2020.05.003","article-title":"Micrornas alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure","volume":"7","author":"Costa","year":"2020","journal-title":"Toxicol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2005.09.008","article-title":"Canadian stem cell scientists take the prize","volume":"122","author":"Sharkis","year":"2005","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Laplane, L., and Solary, E. (2019). Towards a classification of stem cells. Elife, 8.","DOI":"10.7554\/eLife.46563"},{"key":"ref_27","first-page":"212","article-title":"Totipotent, pluripotent or unipotent stem cells: A complex regulatory enigma and fascinating biology","volume":"15","year":"2007","journal-title":"J. Law Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.3816\/CLM.2009.s.031","article-title":"Stem cells and somatic cells: Reprogramming and plasticity","volume":"9","author":"Estrov","year":"2009","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2015.08.010","article-title":"Human embryonic stem cells","volume":"31","author":"Damdimopoulou","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20140367","DOI":"10.1098\/rstb.2014.0367","article-title":"Present and future challenges of induced pluripotent stem cells","volume":"370","author":"Ohnuki","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/ATVBAHA.117.309962","article-title":"Differentiation, evaluation, and application of human induced pluripotent stem cell-derived endothelial cells","volume":"37","author":"Lin","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14 13 11","DOI":"10.1002\/0471140856.tx1413s67","article-title":"The use of induced pluripotent stem cells for the study and treatment of liver diseases","volume":"67","author":"Hansel","year":"2016","journal-title":"Curr. Protoc. Toxicol."},{"key":"ref_33","first-page":"6","article-title":"Multipotent stem cell and current application","volume":"55","author":"Sobhani","year":"2017","journal-title":"Acta Med. Iran."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-6759-9_13","article-title":"Activation and differentiation of mesenchymal stem cells","volume":"1554","author":"Mishra","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/stem.2377","article-title":"Concise review: Stem cell trials using companion animal disease models","volume":"34","author":"Hoffman","year":"2016","journal-title":"Stem Cells"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000381877","article-title":"Stem cells in wound healing: The future of regenerative medicine? A mini-review","volume":"62","author":"Duscher","year":"2016","journal-title":"Gerontology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1556\/oh.2008.28291","article-title":"Mesenchymal stem cells and the immune system\u2014Immunosuppression without drugs?","volume":"149","author":"Kiss","year":"2008","journal-title":"Orv. Hetil."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","article-title":"Mesenchymal stem cells in fibrotic disease","volume":"21","author":"Kramann","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","article-title":"Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects","volume":"21","author":"Berardis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: Therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/archinte.1983.00350120085018","article-title":"Normal liver function. A basis for understanding hepatic disease","volume":"143","author":"Corless","year":"1983","journal-title":"Arch. Intern. Med."},{"key":"ref_44","first-page":"3213","article-title":"In liver fibrosis, dendritic cells govern hepatic inflammation in mice via tnf-alpha","volume":"119","author":"Connolly","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0950-3528(98)90140-3","article-title":"Other hereditary diseases and the liver","volume":"12","author":"Poley","year":"1998","journal-title":"Baillieres Clin. Gastroenterol."},{"key":"ref_46","first-page":"227","article-title":"Hepatitis a and b superimposed on chronic liver disease: Vaccine-preventable diseases","volume":"117","author":"Keeffe","year":"2006","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2018.01.005","article-title":"Viral hepatitis and acute liver failure: Still a problem","volume":"22","author":"Sedhom","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_48","first-page":"161","article-title":"Fatty liver diseases, mechanisms, and potential therapeutic plant medicines","volume":"18","author":"Zhu","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of nafld\/nash","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1381612826666200128094231","article-title":"Causes of mortality in non-alcoholic fatty liver disease (nafld) and alcohol related fatty liver disease (afld)","volume":"26","author":"Johnston","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: A review","volume":"19","author":"Uribe","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: The principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5604\/16652681.1226814","article-title":"Management strategies for liver fibrosis","volume":"16","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"Nafld and liver transplantation: Current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_58","first-page":"3945672","article-title":"Mesenchymal stem cells for liver regeneration in liver failure: From experimental models to clinical trials","volume":"2019","author":"Prieto","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-018-0816-2","article-title":"A pooled analysis of mesenchymal stem cell-based therapy for liver disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/sctm.18-0105","article-title":"Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice","volume":"8","author":"Watanabe","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","article-title":"Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively","volume":"14","author":"Huang","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"Msc-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12964-015-0124-8","article-title":"Msc surface markers (cd44, cd73, and cd90) can identify human msc-derived extracellular vesicles by conventional flow cytometry","volume":"14","author":"Ramos","year":"2016","journal-title":"Cell Commun. Signal."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7078108","DOI":"10.1155\/2020\/7078108","article-title":"Advantages of phosphodiesterase type 5 inhibitors in the management of glucose metabolism disorders: A clinical and translational issue","volume":"2020","author":"Antinozzi","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4130757","DOI":"10.1155\/2019\/4130757","article-title":"Combination treatments of plasma exchange and umbilical cord-derived mesenchymal stem cell transplantation for patients with hepatitis b virus-related acute-on-chronic liver failure: A clinical trial in china","volume":"2019","author":"Xu","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1756-185X.13015","article-title":"Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases","volume":"20","author":"Liang","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microrna biogenesis, mechanisms of actions, and circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Catalanotto, C., Cogoni, C., and Zardo, G. (2016). Microrna in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101712"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1042\/BST0361224","article-title":"How do micrornas regulate gene expression?","volume":"36","author":"Cannell","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhou, M., Hara, H., Dai, Y., Mou, L., Cooper, D.K., Wu, C., and Cai, Z. (2016). Circulating organ-specific micrornas serve as biomarkers in organ-specific diseases: Implications for organ allo- and xeno-transplantation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081232"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kenyon, M., and Babic, A. (2018). The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of Ebmt, Springer.","DOI":"10.1007\/978-3-319-50026-3"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biomaterials.2016.03.020","article-title":"Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair","volume":"90","author":"Shafiq","year":"2016","journal-title":"Biomaterials"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ejh.13036","article-title":"Mirna-15a, mirna-16, mirna-126, mirna-146a, and mirna-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment","volume":"100","author":"Nowicki","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7920358","DOI":"10.1155\/2016\/7920358","article-title":"Stem cell tracking with nanoparticles for regenerative medicine purposes: An overview","volume":"2016","author":"Accomasso","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Nam, S.Y., Ricles, L.M., Suggs, L.J., and Emelianov, S.Y. (2012). In vivo ultrasound and photoacoustic monitoring of mesenchymal stem cells labeled with gold nanotracers. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037267"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1039\/b806051g","article-title":"Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity","volume":"38","author":"Boisselier","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/IJN.S16354","article-title":"Function of mesenchymal stem cells following loading of gold nanotracers","volume":"6","author":"Ricles","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12951-017-0310-5","article-title":"Nanomaterials modulate stem cell differentiation: Biological interaction and underlying mechanisms","volume":"15","author":"Wei","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","article-title":"Exosomes: New players in cell-cell communication","volume":"44","author":"Bang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: Therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2018.11.009","article-title":"Exosomes in inflammation and role as biomarkers","volume":"488","author":"Console","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3892\/ol.2017.5824","article-title":"Role of stem cell-derived exosomes in cancer","volume":"13","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/CIA.S240400","article-title":"Targetting exosomes as a new biomarker and therapeutic approach for alzheimer\u2019s disease","volume":"15","author":"Yin","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1701019","DOI":"10.1002\/adhm.201701019","article-title":"Convenient monitoring system of intracellular microrna expression during adipogenesis via mechanical stimulus-induced exocytosis of lipovesicular mirna beacon","volume":"7","author":"Han","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13287-017-0692-1","article-title":"Mirna profiling of nurown(r): Mesenchymal stem cells secreting neurotrophic factors","volume":"8","author":"Gothelf","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13287-015-0179-x","article-title":"Differentially expressed micrornas in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-beta1-mediated epithelial-mesenchymal transition in hk2 cells","volume":"6","author":"Wang","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/138920101601150105100851","article-title":"Role of microrna 21 in mesenchymal stem cell (msc) differentiation: A powerful biomarker in mscs derived cells","volume":"16","author":"Sekar","year":"2015","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/toxsci\/kfy200","article-title":"Identification of specific microrna biomarkers in early stages of hepatocellular injury, cholestasis, and steatosis in rats","volume":"166","author":"Kagawa","year":"2018","journal-title":"Toxicol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., and Melamed, N. (2008). Serum micrornas are promising novel biomarkers. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003148"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1373\/clinchem.2009.131797","article-title":"Plasma micrornas as sensitive and specific biomarkers of tissue injury","volume":"55","author":"Laterza","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of micrornas in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5582\/irdr.2017.01091","article-title":"Comparison of the extraction and determination of serum exosome and mirna in serum and the detection of mir-27a-3p in serum exosome of als patients","volume":"7","author":"Xu","year":"2018","journal-title":"Intract. Rare Dis. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/dvdy.1231","article-title":"The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung","volume":"222","author":"Lu","year":"2001","journal-title":"Dev. Dyn."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1097\/BRS.0000000000003322","article-title":"Circulating mir-155-5p as a novel biomarker of lumbar degenerative disc disease","volume":"45","author":"Divi","year":"2020","journal-title":"Spine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"dgz300","DOI":"10.1210\/clinem\/dgz300","article-title":"Circulating mir-181c-5p and mir-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis","volume":"105","author":"Ma","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating micrornas peripheral biomarkers for alzheimer\u2019s disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4682172","DOI":"10.1155\/2016\/4682172","article-title":"Microrna expression signature in degenerative aortic stenosis","volume":"2016","author":"Shi","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20100297","article-title":"Serum microrna characterization identifies mir-885-5p as a potential marker for detecting liver pathologies","volume":"120","author":"Gui","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Zhang, X., Zhang, Z., Dai, F., Shi, B., Chen, L., Zhang, X., Zang, G., Zhang, J., Chen, X., and Qian, F. (2014). Comparison of circulating, hepatocyte specific messenger rna and microrna as biomarkers for chronic hepatitis b and c. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092112"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7150\/ijms.11525","article-title":"Dysregulated serum microrna expression profile and potential biomarkers in hepatitis c virus-infected patients","volume":"12","author":"Zhang","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1038\/onc.2008.201","article-title":"Proinflammatory cytokines cause fat10 upregulation in cancers of liver and colon","volume":"27","author":"Lukasiak","year":"2008","journal-title":"Oncogene"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1746-1596-9-135","article-title":"Serum microrna 143 and microrna 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn. Pathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cca.2015.10.002","article-title":"Serum mirna panel as potential biomarkers for chronic hepatitis b with persistently normal alanine aminotransferase","volume":"451","author":"Tan","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"Micrornas in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating micrornas in patients with chronic hepatitis c and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microrna signature in non-alcoholic fatty liver disease: From serum non-coding rnas to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_109","first-page":"425","article-title":"Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis","volume":"16","author":"Saleh","year":"2007","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-rna profiling reveals a role for mir-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of nafld severity: A comprehensive, independent validation of previously postulated serum microrna biomarkers","volume":"8","author":"Conde","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.15.5633","article-title":"Emerging role of micrornas in liver diseases","volume":"15","author":"Bala","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biologicals.2019.02.002","article-title":"Down-regulation of mir-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model","volume":"58","author":"Kazemnejad","year":"2019","journal-title":"Biologicals"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00109-016-1460-x","article-title":"Hur mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis","volume":"95","author":"Chang","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kim, J.Y., Jun, J.H., Park, S.Y., Yang, S.W., Bae, S.H., and Kim, G.J. (2019). Dynamic regulation of mirna expression by functionally enhanced placental mesenchymal stem cells promoteshepatic regeneration in a rat model with bile duct ligation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215299"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Fu, S., Fei, Q., Jiang, H., Chuai, S., Shi, S., Xiong, W., Jiang, L., Lu, C., Atadja, P., and Li, E. (2011). Involvement of histone acetylation of sox17 and foxa2 promoters during mouse definitive endoderm differentiation revealed by microrna profiling. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027965"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Tzur, G., Levy, A., Meiri, E., Barad, O., Spector, Y., Bentwich, Z., Mizrahi, L., Katzenellenbogen, M., Ben-Shushan, E., and Reubinoff, B.E. (2008). Microrna expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003726"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/scd.2009.0224","article-title":"A distinct microrna signature for definitive endoderm derived from human embryonic stem cells","volume":"19","author":"Hinton","year":"2010","journal-title":"Stem Cells Dev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1872-034X.2010.00752.x","article-title":"Expression profiles of mirnas in human embryonic stem cells during hepatocyte differentiation","volume":"41","author":"Kim","year":"2011","journal-title":"Hepatol. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbrc.2011.12.121","article-title":"Mir-30 inhibits tgf-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting snail1","volume":"417","author":"Zhang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/onc.2013.200","article-title":"Mir-30 as a tumor suppressor connects egf\/src signal to erg and emt","volume":"33","author":"Kao","year":"2014","journal-title":"Oncogene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/hep.26252","article-title":"Genome-wide microrna and messenger rna profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling","volume":"57","author":"Wei","year":"2013","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ydbio.2007.09.013","article-title":"The onecut transcription factors hnf-6\/oc-1 and oc-2 regulate early liver expansion by controlling hepatoblast migration","volume":"311","author":"Margagliotti","year":"2007","journal-title":"Dev. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ydbio.2007.02.027","article-title":"Role of the onecut transcription factors in pancreas morphogenesis and in pancreatic and enteric endocrine differentiation","volume":"305","author":"Vanhorenbeeck","year":"2007","journal-title":"Dev. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2009.11.052","article-title":"Mir-495 and mir-218 regulate the expression of the onecut transcription factors hnf-6 and oc-2","volume":"391","author":"Simion","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","article-title":"A feedback loop between the liver-enriched transcription factor network and mir-122 controls hepatocyte differentiation","volume":"142","author":"Laudadio","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/liv.12239","article-title":"Overexpression of mir-122 promotes the hepatic differentiation and maturation of mouse escs through a mir-122\/foxa1\/hnf4a-positive feedback loop","volume":"34","author":"Deng","year":"2014","journal-title":"Liver Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23818","article-title":"Liver-enriched transcription factors regulate microrna-122 that targets cutl1 during liver development","volume":"52","author":"Xu","year":"2010","journal-title":"Hepatology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26422","article-title":"Mir-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells","volume":"58","author":"Gailhouste","year":"2013","journal-title":"Hepatology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"Mir-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.25613","article-title":"Inhibitory effects of microrna 19b in hepatic stellate cell-mediated fibrogenesis","volume":"56","author":"Lakner","year":"2012","journal-title":"Hepatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/jcp.22598","article-title":"Down-regulation of cyclin e1 expression by microrna-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation","volume":"226","author":"Sekiya","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","article-title":"Over-expressed microrna-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation","volume":"583","author":"Ji","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","article-title":"Suppression of hepatic stellate cell activation by microrna-29b","volume":"412","author":"Sekiya","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/ijmm.2013.1356","article-title":"Activation of hepatic stellate cells is suppressed by microrna-150","volume":"32","author":"Zheng","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of mirna-150 and mirna-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"298","author":"Venugopal","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.yexcr.2011.05.001","article-title":"Loss of expression of mir-335 is implicated in hepatic stellate cell migration and activation","volume":"317","author":"Chen","year":"2011","journal-title":"Exp. Cell Res."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Kwiecinski, M., Noetel, A., Elfimova, N., Trebicka, J., Schievenbusch, S., Strack, I., Molnar, L., von Brandenstein, M., Tox, U., and Nischt, R. (2011). Hepatocyte growth factor (hgf) inhibits collagen i and iv synthesis in hepatic stellate cells by mirna-29 induction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024568"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"Mir-15b and mir-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"Microrna-146a modulates tgf-beta1-induced hepatic stellate cell proliferation by targeting smad4","volume":"24","author":"He","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"Mir-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1194\/jlr.M004812","article-title":"Microrna-370 controls the expression of microrna-122 and cpt1alpha and affects lipid metabolism","volume":"51","author":"Iliopoulos","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"Mir-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"Mir-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/MCB.01580-12","article-title":"Micrornas 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition","volume":"33","author":"Wang","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.25846","article-title":"Microrna-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia","volume":"57","author":"Vickers","year":"2013","journal-title":"Hepatology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cellsig.2013.03.003","article-title":"Microrna-1 and microrna-206 suppress lxralpha-induced lipogenesis in hepatocytes","volume":"25","author":"Zhong","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/mnfr.201200237","article-title":"Grape seed proanthocyanidins repress the hepatic lipid regulators mir-33 and mir-122 in rats","volume":"56","author":"Blade","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI44883","article-title":"The liver-specific microrna mir-122 controls systemic iron homeostasis in mice","volume":"121","author":"Castoldi","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Sangokoya, C., Doss, J.F., and Chi, J.T. (2013). Iron-responsive mir-485-3p regulates cellular iron homeostasis by targeting ferroportin. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003408"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1124\/dmd.113.052126","article-title":"Expression variability of absorption, distribution, metabolism, excretion-related micrornas in human liver: Influence of nongenetic factors and association with gene expression","volume":"41","author":"Rieger","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M709382200","article-title":"Post-transcriptional regulation of human pregnane x receptor by micro-rna affects the expression of cytochrome p450 3a4","volume":"283","author":"Takagi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.toxicon.2013.07.002","article-title":"Transcription alterations of micrornas, cytochrome p4501a1 and 3a65, and ahr and pxr in the liver of zebrafish exposed to crude microcystins","volume":"73","author":"Li","year":"2013","journal-title":"Toxicon"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.taap.2012.02.012","article-title":"Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by mir-24","volume":"260","author":"Oda","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"Micrornas regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione s-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.mad.2008.05.004","article-title":"Murine micrornas implicated in liver functions and aging process","volume":"129","author":"Maes","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1499-3872(15)60036-4","article-title":"Role of microrna in liver regeneration","volume":"15","author":"Yi","year":"2016","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanahashi, T., Tanaka, J., Kumada, T., Yoshioka, Y., Kosaka, N., Ochiya, T., and Taguchi, Y.H. (2012). Comprehensive mirna expression analysis in peripheral blood can diagnose liver disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048366"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.25294","article-title":"Circulating micrornas as predictive biomarkers for liver disease progression of chronic hepatitis c (genotype-4) egyptian patients","volume":"91","author":"Fouad","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_163","first-page":"5188","article-title":"Serum levels of micrornas can specifically predict liver injury of chronic hepatitis b","volume":"18","author":"Zhang","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","article-title":"Circulating micrornas in hepatitis b virus-infected patients","volume":"18","author":"Ji","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.hbpd.2018.03.004","article-title":"Serum levels of mirna in patients with hepatitis b virus-associated acute-on-chronic liver failure","volume":"17","author":"Wen","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/hepr.12739","article-title":"Differential expression of plasma microrna-125b in hepatitis b virus-related liver diseases and diagnostic potential for hepatitis b virus-induced hepatocellular carcinoma","volume":"47","author":"Chen","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating micrornas (mir-21, mir-34a, mir-122 and mir-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2015.05.002","article-title":"Longitudinal study of circulating mir-122 in a rat model of non-alcoholic fatty liver disease","volume":"446","author":"Yamada","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Tan, Y., Ge, G., Pan, T., Wen, D., and Gan, J. (2014). A pilot study of serum micrornas panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105192"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the mir-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3727\/105221615X14399878166078","article-title":"Role of noncoding rnas as biomarker and therapeutic targets for liver fibrosis","volume":"16","author":"Teng","year":"2015","journal-title":"Gene Expr."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Chen, Y.J., Zhu, J.M., Wu, H., Fan, J., Zhou, J., Hu, J., Yu, Q., Liu, T.T., Yang, L., and Wu, C.L. (2013). Circulating micrornas as a fingerprint for liver cirrhosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066577"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"Micrornas in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.canlet.2016.01.028","article-title":"Serum mirnas as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma","volume":"373","author":"Li","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jcp.25135","article-title":"Systematic review and meta-analysis: Circulating mirnas for diagnosis of hepatocellular carcinoma","volume":"231","author":"Huang","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/hepr.13078","article-title":"Micrornas as possible biomarkers for hepatocellular carcinoma","volume":"48","author":"Morishita","year":"2018","journal-title":"Hepatol. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/239\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:47:12Z","timestamp":1760179632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":176,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22010239"],"URL":"https:\/\/doi.org\/10.3390\/ijms22010239","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,29]]}}}